Coffee and Blood Pressure Research Resurfaces as Studies Distinguish Dose, Beverage, and Patient Risk

Research on how coffee interacts with high blood pressure is circulating widely again this week, adding a population-specific counterweight to the run of favorable cardiovascular findings that has dominated recent caffeine coverage. According to the South Florida Times on August 13, coverage is revisiting a study published in the Journal of the American Heart Association that found drinking two or more cups of coffee per day was associated with roughly twice the risk of cardiovascular death among people with severe hypertension, defined as blood pressure of 160/100 mm Hg or higher, compared with non-coffee drinkers. Notably, the same research found no elevated risk from a single daily cup at any blood pressure level, and no elevated risk from green tea at any consumption level, despite green tea also containing caffeine.

An 18,600-Person Cohort Isolated Risk to the Most Severe Hypertension Category

The scale and specificity of the research give it lasting weight. According to the American Heart Association’s summary, the study followed more than 18,600 men and women in Japan and found the doubled cardiovascular mortality risk applied only to people in the most severe blood pressure category who drank two or more daily cups, not to people with milder hypertension or normal blood pressure. Senior author Dr. Hiroyasu Iso, director of the Institute for Global Health Policy Research in Tokyo and professor emeritus at Osaka University, said it was to his team’s knowledge the first study to find an association between drinking two or more cups of coffee daily and cardiovascular disease mortality among people with severe hypertension.

Heightened Caffeine Susceptibility May Explain the Dose Threshold

The proposed mechanism centers on vulnerability rather than the beverage itself. According to Dr. Iso’s remarks in the AHA release, people with severe hypertension are more susceptible to the effects of caffeine, and in that population caffeine’s harmful effects may outweigh its protective effects and increase the risk of death. Excessive coffee intake is known to raise blood pressure acutely and can produce anxiety, heart palpitations, and sleep difficulty, effects that compound existing cardiovascular strain. The finding does not overturn the broader literature, which includes evidence that a daily cup may lower mortality risk in heart attack survivors and help prevent heart attacks and strokes in healthy adults; it instead marks where that protective pattern stops applying.

The Green Tea Contrast Points Beyond Caffeine Alone

The study’s most scientifically interesting result may be what did not raise risk. According to the AHA summary, green tea consumption was not associated with increased cardiovascular mortality at any blood pressure level, even though an 8-ounce cup of green or black tea carries 30 to 50 mg of caffeine per Food and Drug Administration figures, compared with 80 to 100 mg in the same size cup of coffee. Researchers suggest two explanations that work together: the lower caffeine dose per serving, and green tea’s polyphenol content, which may exert protective effects that offset caffeine’s pressor action. The contrast reinforces a theme running through this year’s caffeine science, that the compounds traveling with caffeine shape its net effect on the body.

Dose Awareness Emerges as the Practical Takeaway for At-Risk Consumers

For consumers and clinicians, the research translates into arithmetic rather than abstinence. According to the study authors, the findings may support advising people with severe hypertension to avoid excessive coffee, while a single daily cup remained risk-neutral across every blood pressure category. Health coverage circulating this week frames the takeaway accordingly: individuals managing hypertension benefit from knowing the caffeine content of what they consume and keeping servings moderate, lower-dose formats and tea-derived sources present a gentler profile for caffeine-sensitive populations, and anyone with severe hypertension should discuss caffeine intake with a physician. It is the same precision message the caffeine category keeps converging on, applied to its highest-stakes audience.

Jiggle’s caffeine gummies support that kind of precise accounting, delivering a clearly labeled 63 mg of plant-based caffeine per gummy from green tea extract and guarana, with no artificial ingredients. Each resealable pack of 12 gummies retails for $18.99. Learn more at jiggle.cafe.

As cardiovascular research keeps sorting caffeine’s effects by dose, source, and patient profile, the science is settling into a consistent shape: moderation protects most people, and the exceptions are now being mapped precisely enough to guide them.